Low-dose aspirin cuts severe coronavirus risk, study suggests
Fox News
Low-dose aspirin could help keep coronavirus patients off of ventilators, decrease their chances of requiring admission to the intensive care unit and lower the risk of in-hospital death, according to the findings of a new study.
For the study, the team looked at the medical records of more than 400 patients who were admitted to GW Hospital, the University of Maryland Medical Center, Wake Forest Baptist Medical Center, or Northeast Georgia Health System between March and July 2020. Some of the patients (about 24%) received aspirin within the first day of their admission to one of the hospitals or had taken it in the seven days before they were admitted. About 76% did not take aspirin in the study. After adjusting for several factors, the team found that aspirin was associated with a 44% decreased risk of ventilation, a 43% decreased risk of ICU admission, and a 47% reduction in in-hospital mortality.More Related News
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.